GlassScriptPhysician profile
Jonathan Lowe Forbes
NPI 1174943153
$3,032.82
in general payments reported to CMS, 2019-2025
27 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $444 · 2022: $891 · 2023: $480 · 2024: $582 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,658 · Education: $39.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,658.29 |
| Education | $39.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $617.59 | 2021-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $507.78 | 2021-2025 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $270.54 | 2021-2025 | Ofev, Spiriva |
| Genzyme Corporation | $235.16 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $195.64 | 2022-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $182.55 | 2021-2023 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $159.99 | 2022-2025 | Glassia |
| Mylan Specialty L.P. | $83.52 | 2022-2024 | Yupelri |
| Amgen INC. | $80.51 | 2022-2025 | Tezspire |
| Baxter Healthcare | $75.37 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $73.32 | 2022-2025 | Arikayce |
| Abiomed | $71.42 | 2024 | Impella |
| United Therapeutics Corporation | $61.67 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $60.39 | 2021-2022 | |
| Pulmonx Corporation | $45.23 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $41.87 | 2022 | |
| Viatris Specialty LLC | $40.35 | 2025 | Yupelri |
| Advanced Respiratory, INC | $34.04 | 2021 | |
| Grifols USA, LLC | $33.58 | 2023-2025 | Prolastin-C Liquid |
| Gilead Sciences, INC. | $30.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $29.52 | 2022 | |
| Genentech USA, INC. | $24.71 | 2022 | |
| Philips North America LLC | $19.62 | 2024 | (Ak6) Vest Therapy |
| Inogen, INC. | $18.64 | 2024 | |
| Lilly USA, LLC | $14.03 | 2025 | Zepbound |
| Axsome Therapeutics, INC. | $13.95 | 2023 | Sunosi |
| Teva Pharmaceuticals USA, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Forbes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.